Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Search
Close this search box.
GT Medical Technologies Secures $35M Loan from Horizon Technology Finance

GT Medical Technologies Secures $35 Million Loan from Horizon Technology Finance

GT Medical Technologies, Inc., a medical device company with a corporate purpose of improving the lives of patients with brain tumors, announced it has secured a $35 million venture loan facility, of which $15 million has been initially funded from Horizon Technology Finance Corporation, an affiliate of Monroe Capital.

The Company will use the loan proceeds to execute strategic commercial and clinical expansion plans for GammaTile®. These initiatives will drive key corporate objectives that will support access to care, help patients diagnosed with high-grade gliomas, brain metastases, and aggressive meningiomas, and expand GammaTile utilization.

Fintech News: CrowdStrike Introduces Financial Services to Streamline Cybersecurity Platform Integration

“We are delighted to have Horizon’s support as we expand the reach of our innovative targeted radiation solution,” said Per Langoe. “Our partnership with Horizon Technology Finance will allow us to continue our strategic commercial and market expansion initiatives, helping bring GammaTile to more patients in need.”

GammaTile is a bioresorbable collagen tile embedded with Cesium-131 seeds, a radioactive isotope that delivers a high dose of radiation directly to the tumor cavity, helping to reduce tumor recurrence. Unlike external beam radiation therapy, GammaTile uses surgically targeted radiation therapy that minimizes excess radiation exposure and potential damage to healthy tissue.

Fintech News: TCS Partners with Google Cloud to Launch AI-Powered Cybersecurity Solutions to Deal with Advanced Threats

The Company is already backed by top-tier investors, including MVM Partners, Glide Healthcare Partners, MedTech Venture Partners and BlueStone Venture Partners.

“This partnership with Horizon allows us to continue to invest more of our resources into GammaTile and further the company’s expansion within the brain tumor space,” said Sandeep Yadav. “We continue to be driven by the limitations of the current standard of care treatments and will use this funding to expand our commercial teams in order to reach more patients in need of this treatment throughout the country.”

Fintech News: Mastercard Acquires Recorded Future to Boost Digital Security

To share your insights with the FinTech Newsroom, please write to us at news@intentamplify.com

Share With
Contact Us
StatCounter - Free Web Tracker and Counter